Related Experiment Video

Updated: Jun 12, 2026

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Phototherapy for neonatal jaundice--therapeutic effects on more than one level?

Thor Willy Ruud Hansen1

  • 1Neonatal Intensive Care Unit, Women's and Children's Clinic, Oslo University Hospital-Rikshospitalet, Oslo, Norway. t.w.r.hansen@medisin.uio.no

Seminars in Perinatology
|May 25, 2010
PubMed

Insights

Rapid phototherapy effectively reduces bilirubin levels in newborns, potentially preventing kernicterus. Faster photoisomer formation may offer neuroprotection by creating less toxic bilirubin forms.

Area of Science:

  • Neonatal Medicine
  • Phototherapy Research

Background:

  • Phototherapy is standard for neonatal jaundice to prevent bilirubin neurotoxicity.
  • Optimal light parameters (wavelength, irradiance, spectral power) and light sources are studied.
  • Recent kernicterus resurgence necessitates focus on emergency management for severe infant jaundice.

Purpose of the Study:

  • To review evidence on the speed of bilirubin photoisomer formation.
  • To assess the neurotoxicity of different bilirubin isomers.
  • To evaluate the impact of photoisomerization speed on treatment efficacy and neuroprotection.

Main Methods:

  • Literature review of studies on phototherapy for neonatal jaundice.
  • Analysis of research on bilirubin photoisomerization rates.
  • Examination of data on the neurotoxicity of bilirubin and its isomers.

Main Results:

  • Very rapid reductions in total serum bilirubin are achievable with phototherapy.
  • The speed of photoisomer formation is critical for rapid bilirubin reduction.
  • Photoisomers are theoretically more neuroprotective due to their increased polarity.

Conclusions:

  • Accelerated photoisomer formation is key to rapid bilirubin clearance in neonatal jaundice.
  • Understanding bilirubin isomer neurotoxicity is crucial for optimizing phototherapy.
  • Further research into rapid phototherapy techniques may improve outcomes for severely jaundiced infants.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.